Deal Snapshot
Tron to Merge with US Drug Developer Nanopharmaceutics in All-Stock Transaction
Friday 12 August 2022

Idaho, US-based holding company Tron Group, Inc. (OTC: TGRP) and Florida-based clinical-stage pharmaceutical development company Nanopharmaceutics, Inc, have agreed to the merger of Nano with NANOP Acquisition Corp, Inc, a wholly-owned TRON subsidiary, in an all-stock transaction, the company said.

Under the terms of the agreement, Tron will issue five shares of recently authorised and designated class A Preferred stock to Nano shareholders in exchange for all the issued and outstanding shares of Nano.

Date Published: 12/08/2022